Event Details

The Nomination and Remuneration Committee (NRC) of Pine Labs Limited approved the grant of employee stock options at its meeting held on August 10, 2026.

ESOP Grant Specifics

  • Total Options Granted: 15,88,789 employee stock options
  • ESOP Scheme: Pine Labs Employee Stock Option Plan 2025
  • Shareholder Approval: Within the approved limit of 10,20,98,072 stock options
  • Conversion Terms: Each stock option is convertible into one fully paid-up equity share with face value of ₹1

Pricing Details

  • 14,29,976 Options: Priced at ₹136.61 per stock option
  • Calculated as Volume Adjusted Weighted Average Price of last 3 months, discounted by 10%
  • 1,58,813 Options: Priced at ₹5.40 per stock option

Vesting Schedule

  • 15,64,188 Options: 48-month vesting period
  • First vesting of 25% upon completion of 12 months from grant date
  • Subsequent monthly vesting thereafter
  • 24,601 Options: 20 to 36-month vesting period
  • First vesting of 25% upon completion of 12 months from grant date
  • Subsequent monthly vesting thereafter
  • Currently Vested: Nil options out of the total 15,88,789 granted

Exercise Period

The exercise period shall be 5 years from the date of vesting, subject to the terms and conditions of the Scheme.

Additional Terms

Grantee must be an active employee on the date of vesting to be eligible for exercise.

Current Status

  • Options exercised: Not Applicable
  • Money realized by exercise: Not Applicable
  • Shares arising from exercise: Not Applicable
  • Options lapsed: Not Applicable
  • Variation in terms: Not Applicable
  • Subsequent changes/cancellation: Not Applicable
  • Diluted EPS impact: Not Applicable